[Asia Economy Reporter Kwon Jae-hee]
▲ HLB = Decided on a 330 billion KRW rights offering
▲ Medytox = Q2 operating profit of 10.4 billion KRW... 134% increase YoY
▲ Kolon TissueGene = 39 billion KRW rights offering
▲ Suzen Tech = Q2 operating profit of 9.1 billion KRW... turned profitable
▲ Selvas AI = 2 billion KRW rights offering... allocated to Wysiwyg Studios
▲ Lunit = H1 sales of 5.5 billion KRW, up 291%... operating loss of 27.1 billion KRW
▲ Me2on = Q2 operating profit of 7.5 billion KRW... down 26.3% YoY
▲ Seegene = Q2 operating profit of 13 billion KRW... down 91% YoY
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
